Live Breaking News & Updates on Subsidiary Sale

Stay updated with breaking news from Subsidiary sale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

A golden goose gone: Why Glenmark Pharma's investors are unhappy with Nirma deal

Glenmark Pharma has hived off a 75 percent stake in Glenmark Life Sciences, which accounted for nearly 11 percent of its consolidated top line, and had a 20 percent EBITDA contribution, to clear debt ....

Glenmark Pharma , Glenmark Life Sciences , Why Glenmark Pharma , Glenmark Life , Glenmark Life Sciences , Stake Sale , Subsidiary Sale , Pharma Company , Pharma Sector , Stake Divestment ,